Skip to main content
. 2021 May 12;3(2):dlab050. doi: 10.1093/jacamr/dlab050

Figure 2.

Figure 2.

PDR Survey: prevalence of drug resistance and DRMs in Maputo and Tete. HIVDR prevalence by ARV were estimated from RT sequencing using Stanford HIV db v.8.4. Drug resistance levels reported for both study sites (a). The levels of resistance were classified according to Stanford score and reported for NNRTIs. Frequency of DRMs is reported by drug (b) and drug-class (c). EFV, efavirenz; NVP, nevirapine; RPV, rilpivirine; ETR, etravirine.